Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Intravascular Ultrasound Findings in Patients With Very Late Stent Thrombosis After Either Drug-Eluting or Bare-Metal Stent Implantation
2010
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Long-Term Comparison of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization
2011
Extracellular matrix binding mixed micelles for drug delivery applications
2009 StandoutNobel
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Large early variation of residual platelet reactivity in Acute Coronary Syndrome patients treated with clopidogrel
2015 StandoutNobel
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
2009
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists
2008
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation
2010
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Coronary Artery Stents: II. Perioperative Considerations and Management
2008
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease
2008
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Pathology of Drug-Eluting Stents in Humans
2006 Standout
Oral Anticoagulant Therapy
2012 Standout
Stent Thrombosis
2010
Drug-Eluting Stents Compared With Bilateral Internal Thoracic Artery Grafts for Diabetic Patients
2012
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study
2010
Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy
2014
Antiplatelet Drugs
2011
The Danish Civil Registration System as a tool in epidemiology
2014 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting
2009
Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents
2007
Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
2008
Combining Antiplatelet and Anticoagulant Therapies
2009
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
ST-Segment Elevation Myocardial Infarction Due to Early and Late Stent Thrombosis
2008
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
2008
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
2008
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Pathological Findings at Bifurcation Lesions
2010
Temporal Relation Between Clopidogrel Cessation and Stent Thrombosis After Drug-Eluting Stent Implantation
2009
The Danish National Patient Registry: a review of content, data quality, and research potential
2015 Standout
Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy
2010
Current concepts on coronary revascularization in diabetic patients
2011
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
2010
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
2013 Standout
Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?
2012
Land versus water exercise in patients with coronary artery disease: effects on body composition, blood lipids, and physical fitness
2007
Intracoronary Optical Coherence Tomography: A Comprehensive Review
2009
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction
2008
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
2011
New concepts in the design of drug-eluting coronary stents
2013
Third Universal Definition of Myocardial Infarction
2012 Standout
5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions
2010
Drug-Eluting Stent Thrombosis
2008
On the mechanisms of biocompatibility
2008 Standout
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention
2011
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Medication Adherence: WHO Cares?
2011 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Effects of resistance training on muscle strength, exercise capacity, and mobility in middle-aged and elderly patients with coronary artery disease: A meta-analysis
2015
Coronary Stents
2010
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
2013
Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
2013
Predictors of Coronary Stent Thrombosis
2009
In-Stent Restenosis in the Drug-Eluting Stent Era
2010
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Late Coronary Stent Thrombosis
2007
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Curcumin- and natural extract-loaded nanofibres for potential treatment of lung and breast cancer:in vitroefficacy evaluation
2014
Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions
2008
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis
2009
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
2010
Long-Term Mortality After Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Artery Disease
2008
Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals
2014 Standout
Biodegradable metals
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Drug-Eluting Stent and Coronary Thrombosis
2007
Vascular Responses to Drug Eluting Stents
2007
Metallic implant biomaterials
2014 Standout
Safety and Efficacy of Drug-Eluting and Bare Metal Stents
2009
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents
2007
Works of Cyrill Morger being referenced
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
2007
Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice
2008
Influence of water immersion, water gymnastics and swimming on cardiac output in patients with heart failure
2006
Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
2007
Combined endurance/resistance training early on, after a first myocardial infarction, does not induce negative left ventricular remodelling
2008